Gedea Biotech Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.16M
- Investors
-
16
Gedea Biotech General Information
Description
Developer of antibiotic-free therapeutics designed to treat vaginal infections and support vaginal health. The company offers vaginal tablets and therapeutic candidates focused on bacterial vaginosis, vulvovaginal candidiasis, and pre-term birth prevention, enabling women and healthcare providers to manage vaginal infections without the use of antibiotics.
Contact Information
Website
www.gedeabiotech.comCorporate Office
- Medicon Village
- Scheeletorget 1
- 223 81 Lund
- Sweden
Corporate Office
- Medicon Village
- Scheeletorget 1
- 223 81 Lund
- Sweden
Gedea Biotech Timeline
Gedea Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Grant | 25-Aug-2025 | $1.16M | Completed | Clinical Trials - Phase 2 | ||
| 13. Grant | 08-Nov-2023 | Completed | Clinical Trials - Phase 2 | |||
| 12. Later Stage VC | 05-Jun-2023 | Completed | Clinical Trials - Phase 2 | |||
| 11. Grant | 04-Apr-2023 | Completed | Clinical Trials - Phase 2 | |||
| 10. Later Stage VC | 31-Dec-2020 | Completed | Clinical Trials - Phase 2 | |||
| 9. Grant | 11-Dec-2019 | Completed | Startup | |||
| 8. Early Stage VC | 31-Dec-2018 | Completed | Startup | |||
| 7. Grant | 05-Dec-2018 | Completed | Startup | |||
| 6. Accelerator/Incubator | 01-Jan-2018 | $1.34M | Completed | Startup | ||
| 5. Early Stage VC | 22-Dec-2017 | $1.31M | $1.34M | Completed | Startup |
Gedea Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Preference | ||||||||
| Preference | 27,500 | $47.83 | $47.83 | 1x | $47.83 | 24.1% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Gedea Biotech Patents
Gedea Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4731203-A1 | Compositions for promoting growth of lactobacillus crispatus | Pending | 22-Jun-2023 | ||
| WO-2024261110-A1 | Compositions for promoting growth of lactobacillus crispatus | Inactive | 22-Jun-2023 | ||
| EP-4324465-A1 | Compounds for use in the treatment of a microbial infection in the urogenital system | Inactive | 15-Aug-2022 | ||
| AU-2020252268-A1 | Vaginal tablet formulation | Active | 05-Apr-2019 | ||
| AU-2020252268-B2 | Vaginal tablet formulation | Active | 05-Apr-2019 | A61K31/366 |
Gedea Biotech Signals
Gedea Biotech Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Additio Capital | Venture Capital | Minority | ||
| Additio Investment Group | Venture Capital | Minority | ||
| Horizon 2020 | Government | |||
| Medtech4Health | Not-For-Profit Venture Capital |
Gedea Biotech FAQs
-
When was Gedea Biotech founded?
Gedea Biotech was founded in 2015.
-
Where is Gedea Biotech headquartered?
Gedea Biotech is headquartered in Lund, Sweden.
-
What is the size of Gedea Biotech?
Gedea Biotech has 10 total employees.
-
What industry is Gedea Biotech in?
Gedea Biotech’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Gedea Biotech a private or public company?
Gedea Biotech is a Private company.
-
What is Gedea Biotech’s current revenue?
The current revenue for Gedea Biotech is .
-
How much funding has Gedea Biotech raised over time?
Gedea Biotech has raised $6.15M.
-
Who are Gedea Biotech’s investors?
European Innovation Council, Additio Capital, Additio Investment Group, Horizon 2020, and Medtech4Health are 5 of 16 investors who have invested in Gedea Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process